Document is current
Any future updates will be listed below
-
Authors
Knudsen, Andreas D.
Graff, Claus
Nielsen, Jonas Bille
Thomsen, Magda Teresa
Høgh, Julie
Benfield, Thomas
Gerstoft, Jan
Køber, Lars
Kofoed, Klaus F.
Nielsen, Susanne D.
-
Funding
Funding for this research was provided by:
Hjerteforeningen
AstraZeneca
Novartis Pharma
Novo Nordisk Fonden
Lundbeckfonden
Rigshospitalet
Gilead Sciences
Augustinus Fonden
- License Information
-
More Information
Article History
Received: 14 March 2021
Accepted: 23 September 2021
First Online: 21 October 2021
Competing interests
: A.D.K has received a grant from The Danish Heart Foundation and a travelling grant from Gilead unrelated to this manuscript; LK has received personal fees from AstraZeneca and Novartis as speaker at symposia, unrelated to this manuscript; S.D.N. has received unrestricted research grants from Novo Nordisk Foundation, Lundbeck Foundation, Augustinus Foundation, Rigshospitalet Research Council. Advisory board activity for Gilead and GSK/ViiV. All unrelated to this manuscript. All other authors report no competing of interest.
